Early Phase 1 OCD Trial, Recruiting (NCT06720090)

Early Phase 1 OCD Trial, Recruiting NCT06720090 Sponsor: Washington University School of Medicine Condition: OCD

Printed from Voxsanity (voxsanity.com.au) — NCT06720090 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ocd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with OCD (Obsessive-Compulsive Disorder) as your main condition, based on standard diagnostic guidelines
You typically go to bed at 1:00 AM or later
You are between 18 and 35 years old
You speak English

Who may not be able to join:

You are currently taking part in another research study that could affect this one
You have certain other diagnosed mental health or medical conditions (confirm with trial site)
You are currently receiving certain types of treatment (confirm with trial site)
You work night shifts, or you have travelled across more than one time zone from Central Standard Time in the past month
You are currently pregnant
You are currently taking certain medications (confirm with trial site)
You regularly use nicotine products or marijuana

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Rebecca Cox, PhD, Washington University School of Medicine

Phone: 314-935-8111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06720090

Sponsor: Washington University School of Medicine

Phase: Early Phase 1

Status: Recruiting

Condition: OCD

Trial contact: 314-935-8111

More information: https://clinicaltrials.gov/study/NCT06720090

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with OCD (Obsessive-Compulsive Disorder) as your main condition, based on standard diagnostic guidelines
You typically go to bed at 1:00 AM or later
You are between 18 and 35 years old
You speak English

Who may not be able to join:

You are currently taking part in another research study that could affect this one
You have certain other diagnosed mental health or medical conditions (confirm with trial site)
You are currently receiving certain types of treatment (confirm with trial site)
You work night shifts, or you have travelled across more than one time zone from Central Standard Time in the past month
You are currently pregnant
You are currently taking certain medications (confirm with trial site)
You regularly use nicotine products or marijuana

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Washington University School of Medicine

Registry

ClinicalTrials.gov

Start date

16 December 2024

Est. completion

1 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Yale Brown Obsessive-Compulsive Scale (YBOCS); Daily Perseverative Thinking Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov